Friederike Pfeiffer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Friederike Pfeiffer has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Ying Sun
Physiologisches Institut Lehrstuhl für Neurophysiologie, Eberhard-Karls-Universität Tübingen, Tübingen, Deutschland
4 shared publicationsOlga Garaschuk
Institute of Physiology, Department of Neurophysiology, Eberhard Karls University of Tübingen
2 shared publicationsPetra Fallier-Becker
Institute for Pathology and Neuropathology, University of Tübingen, Tübingen, Germany
2 shared publications- Ulrike B. S. Hedrich
Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
2 shared publications Akiko Nishiyama
University of Connecticut
1 shared publication- Akiko Nishiyama
University of Connecticut
1 shared publication
Latest Publications
- 12 October 2026
- Published by Springer Nature in BIOspektrum
- Vol. 32 (6) , 622-624
Untersuchung oligodendroglialer Zellen mit mikroskopischen Methoden
- 12 October 2026
- Published by Springer Nature in BIOspektrum
- Vol. 32 (6) , 622-624
Untersuchung oligodendroglialer Zellen mit mikroskopischen Methoden
- Open Access
- 7 October 2026
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1) , 212
Altered oligodendroglial cell development and increased myelination in SCN2A gain-of-function-linked epilepsy
Gain-of-function variants in SCN2A, encoding the voltage-gated sodium channel Na V 1.2, cause developmental and epileptic encephalopathies characterized by seizures, developmental delay, and white matter abnormalities. While Na V 1.2 is known to regulate neuronal excitability, its role in oligodendroglial cells is unclear. Here, we show that Na V 1.2 is expressed in early oligodendrocyte lineage stages. In mice carrying the gain-of-function Scn2a p.A263V variant, oligodendrocyte precursor cells displayed similar Na V 1.2 expression, but altered electrophysiological properties and calcium signaling. Single-cell transcriptomics revealed stage-specific changes in oligodendroglial maturation during early postnatal development, associated with lower variability and slightly faster conduction velocities. In adult mutant mice, gray matter myelination was increased without changes in oligodendrocyte numbers or myelin structure. Since Na V 1.2 was absent from mature oligodendrocytes, the enhanced myelination likely reflects an activity-dependent adaptation to altered neuronal network activity rather than a primary myelinopathy. These findings identify a glial contribution to SCN2A -related disease mechanisms and underscore the need to consider neuron–glia interactions when developing targeted therapies for epilepsy.
- 7 October 2026
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1) , 212
Open AccessAltered oligodendroglial cell development and increased myelination in SCN2A gain-of-function-linked epilepsy
Gain-of-function variants in SCN2A, encoding the voltage-gated sodium channel Na V 1.2, cause developmental and epileptic encephalopathies characterized by seizures, developmental delay, and white matter abnormalities. While Na V 1.2 is known to regulate neuronal excitability, its role in oligodendroglial cells is unclear. Here, we show that Na V 1.2 is expressed in early oligodendrocyte lineage stages. In mice carrying the gain-of-function Scn2a p.A263V variant, oligodendrocyte precursor cells displayed similar Na V 1.2 expression, but altered electrophysiological properties and calcium signaling. Single-cell transcriptomics revealed stage-specific changes in oligodendroglial maturation during early postnatal development, associated with lower variability and slightly faster conduction velocities. In adult mutant mice, gray matter myelination was increased without changes in oligodendrocyte numbers or myelin structure. Since Na V 1.2 was absent from mature oligodendrocytes, the enhanced myelination likely reflects an activity-dependent adaptation to altered neuronal network activity rather than a primary myelinopathy. These findings identify a glial contribution to SCN2A -related disease mechanisms and underscore the need to consider neuron–glia interactions when developing targeted therapies for epilepsy.
- Open Access
- 16 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1885437
Editorial: Immune functions of neuroglia
Astrocytes strongly contribute to CNS immune responses. Through endfeet, they contribute to the formation and maintenance of the blood-brain barrier (BBB) and perivascular space, thereby controlling immune cell entry. Astrocytes respond to injury or infection through a process termed reactive astrogliosis (3), characterized by morphological and transcriptional changes that can either limit damage or contribute to chronic inflammation. In both physiological and pathological contexts, astrocytes secrete cytokines, chemokines, and growth factors controlling reactive microgliosis and peripheral immune cell recruitment. Astrocytes also regulate extracellular ion balance, neurotransmitter clearance, and metabolic support, all of which indirectly shape inflammatory signaling (4). Oligodendrocytes and OPCs, while primarily involved in myelination, also participate in immune interactions and synaptic pruning and are particularly vulnerable to immune-mediated damage. Finally, ependymal glia control CNS-cerebrospinal fluid (CSF) communications involved in the regulation of CNS immunity. Together, these glial populations form an integrated immunological framework essential for maintaining homeostasis of the nervous tissue and coordinating protective responses. When dysregulated, they contribute to the pathogenesis of neuroinflammatory and neurodegenerative disorders.This research topic aims to explore the potential immune functions of different glial cell types and their interactions with peripheral immune cells that modulate immune responses, and to address the underlying mechanisms, which are often related but not limited to macrogliamicroglia interactions.The review by Haroon et al. provides an overview of what is known about the recently recognized immune capabilities of OPCs, including phagocytosis of myelin debris and the engulfment of axons and presynaptic terminals via low-density lipoprotein receptor-related protein 1 (LRP1). In addition, the authors discuss OPCs' ability to release specific cytokines that regulate the activation and recruitment of immune cells. A subset of OPCs can even present antigen to T cells by expressing major histocompatibility complexes, contributing to the pathogenesis of Multiple Sclerosis (MS). Thus, the functions of OPCs are far more complex than we have anticipated thus far. Similar to what has been described for microglia, oligodendrocytes and OPCs may also possess disease-associated subtypes that differ from those that contribute to myelin formation under homeostatic conditions (5).The MS usually starts with a relapsing-remitting form that then later converts to a progressive form with age and duration of the disease. Atkinson et al. summarize the contribution of microglia to CNS infiltration by T cells, driving the progressive phase of MS and its animal models during aging. The latter specifically target oligodendroglial cells and impair their potential to myelinate. The authors present evidence for the beneficial effects of senolytic therapies on clinical scores in a mouse model of MS, using middle-aged rather than young mice, highlighting the importance of individual patients' age for their vulnerability to disease progression and their responsiveness to therapies. Thus, the interplay between microglia and T cells can modulate the microenvironment of OPCs and thereby influence their remyelination efficiency.Trypanosoma brucei. They show that the parasite load increases in the CSF but not in the brain parenchyma, despite obvious early reactive microgliosis. These findings highlight the important role of microglia in brain protection and their capacity to fight parasitic infection together with infiltrating peripheral macrophages. This study also illustrates the interplay between resident CNS immune cells (microglia) and peripheral immune cells in the CSF, elucidating the sequential involvement of these cells in an in vivo model. Along these lines, Tan et al. delve into the distinct roles that microglia and monocyte-derived macrophages (MDMs) play in defending the retina against inflammation. While microglial cells are responsible for immune surveillance, synaptic pruning, debris clearance, regulation of vascular development and secretion of neurotrophic factors in the healthy retina, the appearance of MDMs in the retina, similar to what was described above for an inflammatory setting at the meninges and in the brain parenchyma, is a sign of disruption of the blood-retina barrier and homeostatic imbalance. This review also discusses the possibilities for distinguishing the two phagocytic cell populations once they reside within the retina at different stages of glaucoma, as well as their distinct activation states and functions, an important prerequisite for specific targeting.In addition to the protective role of neuroglia in combating CNS infections, inflammatory reactions can have detrimental effects on brain health. In an in vitro model of neurodegeneration, Reid and Brown showed that microglia secrete low-density lipoprotein receptor-related protein-associated protein 1 (LRPAP1), most likely in an attempt to protect neurons from the removal of synapses by phagocytosis, which subsequently inhibits the uptake of amyloid β, thus preventing its clearance and export from the brain via LRP1. Interestingly, OPCs use the same phagocytic receptor, LRP1, to internalize synapses (6), and LRP1 is used by glial cells and macrophages to clear myelin debris (7).In summary, much remains to be learned about the immune functions of neuroglia in the CNS, with great potential for developing new therapies. And, it is becoming increasingly clear that it is not enough to focus on them independently. One must consider their interactions and mutual influence. In the context of brain diseases that lead to BBB breakdown (e.g., inflammation and neurodegeneration), the contributions of peripheral immune cells and modulation of their functional properties by local glial...
- 16 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1885437
Open AccessEditorial: Immune functions of neuroglia
Astrocytes strongly contribute to CNS immune responses. Through endfeet, they contribute to the formation and maintenance of the blood-brain barrier (BBB) and perivascular space, thereby controlling immune cell entry. Astrocytes respond to injury or infection through a process termed reactive astrogliosis (3), characterized by morphological and transcriptional changes that can either limit damage or contribute to chronic inflammation. In both physiological and pathological contexts, astrocytes secrete cytokines, chemokines, and growth factors controlling reactive microgliosis and peripheral immune cell recruitment. Astrocytes also regulate extracellular ion balance, neurotransmitter clearance, and metabolic support, all of which indirectly shape inflammatory signaling (4). Oligodendrocytes and OPCs, while primarily involved in myelination, also participate in immune interactions and synaptic pruning and are particularly vulnerable to immune-mediated damage. Finally, ependymal glia control CNS-cerebrospinal fluid (CSF) communications involved in the regulation of CNS immunity. Together, these glial populations form an integrated immunological framework essential for maintaining homeostasis of the nervous tissue and coordinating protective responses. When dysregulated, they contribute to the pathogenesis of neuroinflammatory and neurodegenerative disorders.This research topic aims to explore the potential immune functions of different glial cell types and their interactions with peripheral immune cells that modulate immune responses, and to address the underlying mechanisms, which are often related but not limited to macrogliamicroglia interactions.The review by Haroon et al. provides an overview of what is known about the recently recognized immune capabilities of OPCs, including phagocytosis of myelin debris and the engulfment of axons and presynaptic terminals via low-density lipoprotein receptor-related protein 1 (LRP1). In addition, the authors discuss OPCs' ability to release specific cytokines that regulate the activation and recruitment of immune cells. A subset of OPCs can even present antigen to T cells by expressing major histocompatibility complexes, contributing to the pathogenesis of Multiple Sclerosis (MS). Thus, the functions of OPCs are far more complex than we have anticipated thus far. Similar to what has been described for microglia, oligodendrocytes and OPCs may also possess disease-associated subtypes that differ from those that contribute to myelin formation under homeostatic conditions (5).The MS usually starts with a relapsing-remitting form that then later converts to a progressive form with age and duration of the disease. Atkinson et al. summarize the contribution of microglia to CNS infiltration by T cells, driving the progressive phase of MS and its animal models during aging. The latter specifically target oligodendroglial cells and impair their potential to myelinate. The authors present evidence for the beneficial effects of senolytic therapies on clinical scores in a mouse model of MS, using middle-aged rather than young mice, highlighting the importance of individual patients' age for their vulnerability to disease progression and their responsiveness to therapies. Thus, the interplay between microglia and T cells can modulate the microenvironment of OPCs and thereby influence their remyelination efficiency.Trypanosoma brucei. They show that the parasite load increases in the CSF but not in the brain parenchyma, despite obvious early reactive microgliosis. These findings highlight the important role of microglia in brain protection and their capacity to fight parasitic infection together with infiltrating peripheral macrophages. This study also illustrates the interplay between resident CNS immune cells (microglia) and peripheral immune cells in the CSF, elucidating the sequential involvement of these cells in an in vivo model. Along these lines, Tan et al. delve into the distinct roles that microglia and monocyte-derived macrophages (MDMs) play in defending the retina against inflammation. While microglial cells are responsible for immune surveillance, synaptic pruning, debris clearance, regulation of vascular development and secretion of neurotrophic factors in the healthy retina, the appearance of MDMs in the retina, similar to what was described above for an inflammatory setting at the meninges and in the brain parenchyma, is a sign of disruption of the blood-retina barrier and homeostatic imbalance. This review also discusses the possibilities for distinguishing the two phagocytic cell populations once they reside within the retina at different stages of glaucoma, as well as their distinct activation states and functions, an important prerequisite for specific targeting.In addition to the protective role of neuroglia in combating CNS infections, inflammatory reactions can have detrimental effects on brain health. In an in vitro model of neurodegeneration, Reid and Brown showed that microglia secrete low-density lipoprotein receptor-related protein-associated protein 1 (LRPAP1), most likely in an attempt to protect neurons from the removal of synapses by phagocytosis, which subsequently inhibits the uptake of amyloid β, thus preventing its clearance and export from the brain via LRP1. Interestingly, OPCs use the same phagocytic receptor, LRP1, to internalize synapses (6), and LRP1 is used by glial cells and macrophages to clear myelin debris (7).In summary, much remains to be learned about the immune functions of neuroglia in the CNS, with great potential for developing new therapies. And, it is becoming increasingly clear that it is not enough to focus on them independently. One must consider their interactions and mutual influence. In the context of brain diseases that lead to BBB breakdown (e.g., inflammation and neurodegeneration), the contributions of peripheral immune cells and modulation of their functional properties by local glial...
- Open Access
- 29 September 2025
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (8) , 3551-3552
Oligodendrocyte precursor cells in the substantia nigra: Implications for Parkinson’s disease
- 29 September 2025
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (8) , 3551-3552
Open AccessOligodendrocyte precursor cells in the substantia nigra: Implications for Parkinson’s disease
- Open Access
Oligodendrocyte precursor cells establish contacts with somata of active neurons
Oligodendrocyte precursor cells (OPCs) generate myelinating oligodendrocytes and interact with synapses to regulate neuronal networks. Neuronal activity induces proliferation or differentiation of OPCs, but it is unknown whether OPCs in turn affect neuronal activity. Here, we show that OPCs establish close contacts with the somata of active neurons. We found that neurons contacted by OPCs and their processes display reduced calcium signals, indicating that they regulate their activity.
Open AccessOligodendrocyte precursor cells establish contacts with somata of active neurons
Oligodendrocyte precursor cells (OPCs) generate myelinating oligodendrocytes and interact with synapses to regulate neuronal networks. Neuronal activity induces proliferation or differentiation of OPCs, but it is unknown whether OPCs in turn affect neuronal activity. Here, we show that OPCs establish close contacts with the somata of active neurons. We found that neurons contacted by OPCs and their processes display reduced calcium signals, indicating that they regulate their activity.
- Open Access
- 27 January 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (1) , e16298
Interactions of Oligodendrocyte Precursor Cells and Dopaminergic Neurons in the Mouse Substantia Nigra
Parkinson's disease (PD) is a prevalent neurodegenerative disease caused by the death of dopaminergic neurons within the substantia nigra pars compacta (SNpc) region of the midbrain. Recent genomic and single cell sequencing data identified oligodendrocytes and oligodendrocyte precursor cells (OPCs) to confer genetic risk in PD, but their biological role is unknown. Although SNpc dopaminergic neurons are scarcely or thinly myelinated, there is a gap in the knowledge concerning the physiological interactions between dopaminergic neurons and oligodendroglia. We sought to investigate the distribution of OPCs with regard to the myelination state in the mouse substantia nigra (SN) by high‐resolution imaging to provide a morphological assessment of OPC‐dopaminergic neuron interactions and quantification of cell numbers across different age groups. OPCs are evenly distributed in the midbrain throughout the lifespan and they physically interact with both the soma and axons of dopaminergic neurons. The presence of OPCs and their interaction with dopaminergic neurons does not correlate with the distribution of myelin. Myelination is sparse in the SNpc, including dopaminergic fibers originating from the SNpc and projecting through the substantia nigra pars reticulata (SNpr). We report that OPCs and dopaminergic neurons exist in a 1:1 ratio in the SNpc, with OPCs accounting for 15%–16% of all cells in the region across all age groups. This description of OPC‐dopaminergic neuron interaction in the midbrain provides a first look at their longitudinal distribution in mice, suggesting additional functions of OPCs beyond their differentiation into myelinating oligodendrocytes. image
- 27 January 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (1) , e16298
Open AccessInteractions of Oligodendrocyte Precursor Cells and Dopaminergic Neurons in the Mouse Substantia Nigra
Parkinson's disease (PD) is a prevalent neurodegenerative disease caused by the death of dopaminergic neurons within the substantia nigra pars compacta (SNpc) region of the midbrain. Recent genomic and single cell sequencing data identified oligodendrocytes and oligodendrocyte precursor cells (OPCs) to confer genetic risk in PD, but their biological role is unknown. Although SNpc dopaminergic neurons are scarcely or thinly myelinated, there is a gap in the knowledge concerning the physiological interactions between dopaminergic neurons and oligodendroglia. We sought to investigate the distribution of OPCs with regard to the myelination state in the mouse substantia nigra (SN) by high‐resolution imaging to provide a morphological assessment of OPC‐dopaminergic neuron interactions and quantification of cell numbers across different age groups. OPCs are evenly distributed in the midbrain throughout the lifespan and they physically interact with both the soma and axons of dopaminergic neurons. The presence of OPCs and their interaction with dopaminergic neurons does not correlate with the distribution of myelin. Myelination is sparse in the SNpc, including dopaminergic fibers originating from the SNpc and projecting through the substantia nigra pars reticulata (SNpr). We report that OPCs and dopaminergic neurons exist in a 1:1 ratio in the SNpc, with OPCs accounting for 15%–16% of all cells in the region across all age groups. This description of OPC‐dopaminergic neuron interaction in the midbrain provides a first look at their longitudinal distribution in mice, suggesting additional functions of OPCs beyond their differentiation into myelinating oligodendrocytes. image
- Open Access
Axonopathy and altered synaptic development in early hippocampal epileptogenesis of Dravet syndrome
Dravet syndrome caused by SCN1A variants is a severe developmental epileptic encephalopathy (DEE) characterized by pharmaco-resistant epileptic seizures and progressive neurodevelopmental decline with cognitive impairment and autism-spectrum-traits. Numerous preceding studies indicate that the initial pathophysiology due to impaired Na V 1.1 function mainly derives from reduced interneuron firing leading to a network hyperexcitability (Bender et al. 2012). However, little is known how epileptogenesis and generally disease pathogenesis progress from the inborn molecular defect to infantile seizure onset. We address this question in a Dravet mouse model by comprehensive single-cell RNA sequencing and selected downstream analysis via single-cell electrophysiology, histology, live cell imaging and electron microscopy. Our data reveal a continuum of early primary (preseizure) and secondary (post-seizure onset) transcriptomic changes in various cell populations in the hippocampus. Focusing on cornu ammonis , we find a number of transcriptional pathways that are dysregulated including synaptic transmembrane adhesion molecules of the neurexin superfamily and voltage-gated ion channels. Further investigations support an ultrastructural and functional axonopathy and synaptopathy of parvalbumin interneurons. These processes precede somatic firing impairment and seizures suggesting they underlie fundamental early-phase disease mechanisms. Taken together we provide a cellularly resolved transcriptomic resource of early disease phases of Dravet syndrome and demonstrate epileptogenesis beyond Na V 1.1 loss-of-function during an early developmental time window of CNS maturation. Altogether these data establish proof-of principle that the concept of epileptogenesis, originally devised for acquired forms of epilepsy, similarly applies to genetic epilepsies and DEEs.
Open AccessAxonopathy and altered synaptic development in early hippocampal epileptogenesis of Dravet syndrome
Dravet syndrome caused by SCN1A variants is a severe developmental epileptic encephalopathy (DEE) characterized by pharmaco-resistant epileptic seizures and progressive neurodevelopmental decline with cognitive impairment and autism-spectrum-traits. Numerous preceding studies indicate that the initial pathophysiology due to impaired Na V 1.1 function mainly derives from reduced interneuron firing leading to a network hyperexcitability (Bender et al. 2012). However, little is known how epileptogenesis and generally disease pathogenesis progress from the inborn molecular defect to infantile seizure onset. We address this question in a Dravet mouse model by comprehensive single-cell RNA sequencing and selected downstream analysis via single-cell electrophysiology, histology, live cell imaging and electron microscopy. Our data reveal a continuum of early primary (preseizure) and secondary (post-seizure onset) transcriptomic changes in various cell populations in the hippocampus. Focusing on cornu ammonis , we find a number of transcriptional pathways that are dysregulated including synaptic transmembrane adhesion molecules of the neurexin superfamily and voltage-gated ion channels. Further investigations support an ultrastructural and functional axonopathy and synaptopathy of parvalbumin interneurons. These processes precede somatic firing impairment and seizures suggesting they underlie fundamental early-phase disease mechanisms. Taken together we provide a cellularly resolved transcriptomic resource of early disease phases of Dravet syndrome and demonstrate epileptogenesis beyond Na V 1.1 loss-of-function during an early developmental time window of CNS maturation. Altogether these data establish proof-of principle that the concept of epileptogenesis, originally devised for acquired forms of epilepsy, similarly applies to genetic epilepsies and DEEs.
- Open Access
- 31 July 2023
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 475 (10) , 1129-1131
Commentary on: Bai, X., Zhao, N., Koupourtidou, C., Fang, L.-P., Schwarz, V., Caudal, L.C., Zhao, R., Hirrlinger, J., Walz, W., Bian, S., Huang, W., Ninkovic, J., Kirchhoff, F., Scheller, A. “In the mouse cortex, oligodendrocytes regain a plastic capacity, transforming into astrocytes after acute injury”
- 31 July 2023
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 475 (10) , 1129-1131
Open AccessCommentary on: Bai, X., Zhao, N., Koupourtidou, C., Fang, L.-P., Schwarz, V., Caudal, L.C., Zhao, R., Hirrlinger, J., Walz, W., Bian, S., Huang, W., Ninkovic, J., Kirchhoff, F., Scheller, A. “In the mouse cortex, oligodendrocytes regain a plastic capacity, transforming into astrocytes after acute injury”
- Open Access
- 15 October 2022
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 474 (12) , 1275-1283
Cuprizone feeding induces swollen astrocyte endfeet
The cuprizone model is a widely used model to study the pathogenesis of multiple sclerosis (MS). Due to the selective loss of mature oligodendrocytes and myelin, it is mainly being used to study demyelination and the mechanisms of remyelination, as well as the efficiency of compounds or therapeutics aiming at remyelination. Although early investigations using high dosages of cuprizone reported the occurrence of hydrocephalus, it has long been assumed that cuprizone feeding at lower dosages does not induce changes at the blood–brain barrier (BBB). Here, by analyzing BBB ultrastructure with high-resolution electron microscopy, we report changes at astrocytic endfeet surrounding vessels in the brain parenchyma. Particularly, edema formation around blood vessels and swollen astrocytic endfeet already occurred after feeding low dosages of cuprizone. These findings indicate changes in BBB function that will have an impact on the milieu of the central nervous system (CNS) in the cuprizone model and need to be considered when studying the mechanisms of de- and remyelination.
- 15 October 2022
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 474 (12) , 1275-1283
Open AccessCuprizone feeding induces swollen astrocyte endfeet
The cuprizone model is a widely used model to study the pathogenesis of multiple sclerosis (MS). Due to the selective loss of mature oligodendrocytes and myelin, it is mainly being used to study demyelination and the mechanisms of remyelination, as well as the efficiency of compounds or therapeutics aiming at remyelination. Although early investigations using high dosages of cuprizone reported the occurrence of hydrocephalus, it has long been assumed that cuprizone feeding at lower dosages does not induce changes at the blood–brain barrier (BBB). Here, by analyzing BBB ultrastructure with high-resolution electron microscopy, we report changes at astrocytic endfeet surrounding vessels in the brain parenchyma. Particularly, edema formation around blood vessels and swollen astrocytic endfeet already occurred after feeding low dosages of cuprizone. These findings indicate changes in BBB function that will have an impact on the milieu of the central nervous system (CNS) in the cuprizone model and need to be considered when studying the mechanisms of de- and remyelination.
- Open Access
Reciprocal Interactions between Oligodendrocyte Precursor Cells and the Neurovascular Unit in Health and Disease
Oligodendrocyte precursor cells (OPCs) are mostly known for their capability to differentiate into oligodendrocytes and myelinate axons. However, they have been observed to frequently interact with cells of the neurovascular unit during development, homeostasis, and under pathological conditions. The functional consequences of these interactions are largely unclear, but are increasingly studied. Although OPCs appear to be a rather homogenous cell population in the central nervous system (CNS), they present with an enormous potential to adapt to their microenvironment. In this review, it is summarized what is known about the various roles of OPC-vascular interactions, and the circumstances under which they have been observed.
Open AccessReciprocal Interactions between Oligodendrocyte Precursor Cells and the Neurovascular Unit in Health and Disease
Oligodendrocyte precursor cells (OPCs) are mostly known for their capability to differentiate into oligodendrocytes and myelinate axons. However, they have been observed to frequently interact with cells of the neurovascular unit during development, homeostasis, and under pathological conditions. The functional consequences of these interactions are largely unclear, but are increasingly studied. Although OPCs appear to be a rather homogenous cell population in the central nervous system (CNS), they present with an enormous potential to adapt to their microenvironment. In this review, it is summarized what is known about the various roles of OPC-vascular interactions, and the circumstances under which they have been observed.